EA
HAE icon

Edge Advisors’s Haemonetics HAE Stock Holding History

Edge Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$11K Sell
128
-138
-52% -$11.7K ﹤0.01% 691
2018
Q1 		$19K Hold
266
– – ﹤0.01% 651
2017
Q4 		$15K Hold
266
– – ﹤0.01% 703
2017
Q3 		$11K Sell
266
-181
-40% -$7.52K ﹤0.01% 721
2017
Q2 		$17K Hold
447
– – ﹤0.01% 678
2017
Q1 		$17K Buy
447
+7
+2% +$273 ﹤0.01% 694
2016
Q4 		$17K Buy
+440
New +$16.6K ﹤0.01% 639

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Edge Advisors's HAE Position: Q2 2018 in Review

Edge Advisors reduced its Haemonetics (HAE) stake by 52% in Q2 2018, selling an estimated $11.7K and leaving 128 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #691.

Edge Advisors first reported a position in HAE in Q4 2016 and has held it in 7 quarters since. The position peaked at $19K in Q1 2018. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

  • Edge Advisors held 128 shares of Haemonetics worth $11K as of Q2 2018.
  • Edge Advisors sold 138 Haemonetics shares in Q2 2018, an estimated $11.7K.
  • Haemonetics made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #691 holding.
  • Edge Advisors first reported a position in Haemonetics in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Haemonetics position peaked at $19K in Q1 2018.
  • 293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.